PDGF in Hair Growth The Platelet-Derived Growth Factor Co…

PDGF: From Wound Healing to Hair Regeneration

Platelet-derived growth factor (PDGF) was first identified as a mitogen released from platelets during blood clotting, where it stimulates the proliferation of fibroblasts and smooth muscle cells needed for wound repair. But PDGF has a second, equally important role: it is a critical signaling molecule in hair follicle development, cycling, and regeneration. Understanding PDGF’s dual identity — as both a wound healing factor and a hair growth regulator — provides insight into why procedures like PRP (platelet-rich plasma) therapy may work for hair loss.

PDGF in Hair Growth The Platelet-Derived Growth Factor Connection

PDGF exists as several dimeric isoforms: PDGF-AA, PDGF-BB, PDGF-AB, PDGF-CC, and PDGF-DD. These isoforms signal through two tyrosine kinase receptors: PDGFRα (which binds all isoforms) and PDGFRβ (which binds PDGF-BB and PDGF-DD preferentially). Both receptors are expressed in hair follicle tissue, with PDGFRα particularly important for stem cell activation.

PDGF in Hair Follicle Development

During embryonic hair follicle development, PDGF signaling plays a specific role in the mesenchymal compartment:

Dermal Condensation

The dermal condensate — the precursor to the dermal papilla — forms through PDGF-mediated mesenchymal cell recruitment. PDGF-A, produced by the epithelial placode, signals through PDGFRα on mesenchymal cells, attracting them to cluster beneath the placode. Mice lacking PDGF-A or PDGFRα fail to form proper dermal condensates, resulting in dramatically reduced hair follicle numbers.

Dermal Papilla Maturation

After condensation, PDGF signaling continues to support dermal papilla cell survival and function. PDGF promotes the expression of other growth factors by dermal papilla cells — including VEGF, FGF7, and BMP6 — that are essential for follicle morphogenesis.

PDGF in Adult Hair Follicle Cycling

The Adipose-Follicle PDGF Axis

As discussed in the adipose tissue article, PDGFA produced by subcutaneous adipose precursor cells is a key signal for anagen initiation. During telogen, these precursor cells proliferate and produce PDGFA, which activates PDGFRα on hair germ cells (the immediate progeny of bulge stem cells), pushing them into the cell cycle and initiating anagen.

PDGF in the Dermal Papilla

The dermal papilla itself produces PDGF-BB, which signals through PDGFRβ on perifollicular mesenchymal cells. This signaling:

Promotes angiogenesis around the follicle (supporting the increased blood supply needed during anagen)
Maintains the dermal sheath (the connective tissue sleeve that supports follicle structure)
Supports perifollicular fibroblast survival, which contributes to the ECM needed for follicle integrity

PDGF and Follicle Regeneration After Injury

After skin injury, PDGF is one of the first growth factors released at the wound site. It promotes wound healing but also stimulates hair follicle neogenesis in certain contexts. A 2007 study showed that wound-induced hair neogenesis in mice — a phenomenon where new hair follicles form in healing wounds — depends on PDGF signaling.

The PRP Connection

Platelet-rich plasma (PRP) therapy for hair loss involves concentrating platelets from the patient’s blood and injecting them into the scalp. When platelets are activated, they release their alpha granule contents, which include:

PDGF-AA, PDGF-AB, PDGF-BB: The primary platelet-derived growth factors
TGF-β1: Promotes fibroblast activation but also catagen
VEGF: Promotes angiogenesis
EGF: Epidermal growth factor
IGF-1: Insulin-like growth factor
FGF2: Basic fibroblast growth factor
BMPs: Bone morphogenetic proteins

PDGF is the most abundant growth factor in PRP, and its presence may be a primary reason why PRP therapy shows benefit in some patients with androgenetic alopecia. PDGF from PRP could:

Activate PDGFRα on hair germ cells, promoting anagen initiation
Support dermal papilla cell survival and function
Promote angiogenesis around miniaturized follicles
Stimulate adipose precursor cells in the subcutaneous layer

However, PRP’s variable clinical results may reflect variability in PDGF content (which depends on platelet concentration, activation method, and individual patient factors) and the simultaneous delivery of TGF-β1 (which promotes catagen), creating a mixed signal.

PDGF’s Role in Dermal Papilla Cell Maintenance

The dermal papilla is the follicle’s command center, and its cells are essential for producing the signals that drive anagen. PDGF supports dermal papilla cell function through several mechanisms:

Anti-Senescence Effects

PDGF signaling through PDGFRβ activates PI3K-Akt and MAPK pathways in dermal papilla cells, promoting their survival and preventing senescence. In aged or miniaturized follicles, reduced PDGF signaling may contribute to dermal papilla cell senescence and loss of signaling capacity.

Aggregative Behavior

Dermal papilla cells naturally form aggregates — a behavior that is essential for their inductive capacity (their ability to instruct follicle epithelium to grow). PDGF promotes this aggregative behavior. When dermal papilla cells are cultured without PDGF, they lose their aggregative tendency and their ability to induce hair growth.

Growth Factor Production

PDGF-treated dermal papilla cells produce more VEGF, FGF7, and BMP6, amplifying their growth-promoting effects on the follicle epithelium.

Therapeutic Approaches

Optimized PRP

Standardizing PRP preparation to maximize PDGF content while minimizing TGF-β1 could improve clinical outcomes. Double-spin methods and specific anticoagulants (e.g., sodium citrate rather than EDTA) may preserve more PDGF activity.

Recombinant PDGF

Recombinant PDGF-BB (becaplermin/Regranex) is FDA-approved for diabetic wound healing. While not approved for hair loss, its wound healing application demonstrates that topical PDGF delivery is feasible and safe. Topical PDGF for hair loss could theoretically provide more consistent PDGF dosing than PRP.

PDGF-Loaded Biomaterials

Hydrogels and microneedle patches loaded with PDGF could provide sustained release directly to the follicle region, overcoming the rapid clearance of injected PRP.

PDGFRα Agonists

Small molecule PDGFRα agonists could substitute for PDGF itself. While no such compound is currently available, the validated role of PDGFRα in stem cell activation makes this an attractive target.

Key Takeaways

PDGF is essential for hair follicle development and cycling — it recruits mesenchymal cells to form the dermal papilla and activates stem cells for anagen.
PDGF from adipose tissue is a key anagen signal — the subcutaneous fat layer produces PDGFA that activates hair germ cells.
PDGF is the most abundant growth factor in PRP — this may be the primary mechanism by which PRP therapy benefits hair growth.
PDGF supports dermal papilla cell function — it prevents senescence and promotes the aggregative behavior essential for inductive capacity.
PRP’s variable results may reflect variable PDGF content — standardizing PDGF delivery could improve outcomes.
Recombinant PDGF or PDGF-loaded biomaterials could replace PRP — providing more consistent dosing and sustained delivery.

Beyond PRP: Next-Generation PDGF Delivery for Hair Loss

While PRP remains the most accessible PDGF delivery method, its limitations — variable composition, rapid clearance, and inconsistent clinical results — have motivated the development of next-generation PDGF delivery systems.

Sustained-Release Biomaterials

Hydrogels loaded with recombinant PDGF can provide sustained release over days to weeks, maintaining therapeutic PDGF levels in the follicle tissue much longer than a single PRP injection. A 2021 study demonstrated that PDGF-loaded hydrogel applied to mouse skin promoted more robust hair growth than equivalent-dose PDGF injection, likely because the sustained release maintained PDGF signaling throughout the anagen initiation period.

Microneedle Patch Delivery

Dissolving microneedle patches containing PDGF can deliver the growth factor directly to the follicle region through the stratum corneum barrier. The microneedles dissolve within minutes, releasing their cargo into the dermal tissue. This approach avoids the pain and bruising of injection while providing more consistent dosing than PRP.

PDGF-Loaded Nanoparticles

Nanoparticles engineered to target the dermal papilla could deliver PDGF specifically to the follicle command center, maximizing the signaling impact while minimizing the dose needed. Surface functionalization with ligands that bind dermal papilla-specific markers could achieve this targeting.

Gene Therapy

Adenoviral vectors encoding PDGF-BB could provide sustained PDGF production in the scalp for weeks after a single administration. While gene therapy raises safety concerns, the localized nature of scalp application and the ability to use tissue-specific promoters could mitigate systemic risks.

The Senescence-Associated Secretory Phenotype in Follicle Stem Cells

Senescent follicle stem cells do not simply stop dividing — they actively secrete pro-inflammatory cytokines, chemokines, and matrix-degrading enzymes collectively termed the senescence-associated secretory phenotype (SASP). Key SASP components in follicle stem cells include IL-6, IL-8, MMP-3, and MCP-1, which create a chronic inflammatory microenvironment that impairs the function of neighboring non-senescent stem cells. This “bystander effect” means that even a small population of senescent stem cells can compromise the regenerative capacity of the entire stem cell pool.

PDGF in Hair Growth The Platelet-Derived Growth Factor Connection